Furthermore, we showed that HMGCR inhibitors may enhance radiotherapy efficacy by boosting anti-tumor activity through further activation of the cGAS–STING pathway, which promotes the infiltration and function of CD8+ T cells. Here, CD8A is linked to neoplasm.